Observational investigation in hospital of Songling Xuemaikang Capsule for treating primary hypertension, a real word study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-11001612

Enrollment

Unknown

Registered

2011-11-05

Start date

2011-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary hypertension

Interventions

A:Songling Xuemaikang Capsule

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Participants with primary hypertension.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Changes in Diastolic Pressure;	—

Secondary

Measure	Time frame
Changes in Clinical Symptoms and Signs;Standard-reaching Rate of Blood Pressure;BMI;Satisfaction of participants;Traditional Chinese Medicine Symptom;Changes in Systolic Pressure;Blood Pressure;	—

Countries

China

Contacts

Public ContactGao Ying

gaoying973@126.com+86 01084013209

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026